The diagnosis of HHT is established when a suspected patient bears a pathogenic variant (‘mutation’) in ENG, ACVRL1, SMAD4, or GDF2 or presents with at least three of the four Curaçao criteria [2,3]. This evidence concerns the gene ENG and hereditary hemorrhagic telangiectasia.